KADCYLA® (ado-trastuzumab emtansine) Preparation & Storage in EBC

Familiarize yourself with KADCYLA® (ado-trastuzumab emtansine) preparation and storage in HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information.

Trastuzumab (Intravenous) Including Biosimilars of Trastuzumab

Ado-trastuzumab emtansine (Kadcyla®) » ADC Review

Kadcyla 100 mg Powder for Concentrate for Solution for Infusion

Risk-based Approaches for Optimizing Treatment in HER2-Positive

Kadcyla (ado-trastuzumab emtansine) - 160 mg Vial For Injection

Genentech's Kadcyla Is the First Targeted Therapy to Show

Herceptin (Trastuzumab): Side Effects, Uses, Dosage, Interactions

Kadcyla Full Prescribing Information, Dosage & Side Effects

Clinical Trial Results in EBC KADCYLA® (ado-trastuzumab emtansine)

WO2015164665A1 - Methods of treating early breast cancer with

How KADCYLA® (ado-trastuzumab emtansine) is Thought to Work in EBC

HER-2 directed therapy in advanced breast cancer